The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain. (Q48447583)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 1998

Language	Label	Description	Also known as
English	The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain.	scientific article published in April 1998

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

author name string

Javed A

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

Van de Kar LD

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

Gray TS

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

791

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

67-74

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

1-2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

The neuroendocrine response to d-fenfluramine in women with premenstrual depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Possible link between brain serotonin metabolism and methionine sulfoximine-induced hypothermia and associated behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Modulation of light-induced C-Fos expression in the suprachiasmatic nuclei by 5-HT1A receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Role of 5-HT receptors in the effect of d-fenfluramine on feeding patterns in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Neuroendocrine and neurochemical responses to novelty stress in young and old male F344 rats: effects of d-fenfluramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Serotonin2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Effect of chronic dexfenfluramine on Fos in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Effect of the 5HT2 antagonist ritanserin on food intake and on 5HT-induced anorexia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

P-chloroamphetamine induces c-fos in rat brain: a study of serotonin2A/2C receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Involvement of 5-HT1A receptor mechanisms in the inhibitory effects of methamphetamine on photic responses in the rodent suprachiasmatic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Effect of continuous infusions of dexfenfluramine on food intake, body weight and brain amines in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Expression of c-fos protein in brain: metabolic mapping at the cellular level

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Hypothalamic serotonin in the control of meal patterns and macronutrient selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

D-fenfluramine effects on hypothalamic monoamine activities and their hormonal correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Distribution of 5-HT4 receptor mRNA in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Behavioural evidence thatd-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Medial hypothalamic serotonin: effects on deprivation and norepinephrine-induced eating.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Comparative localization of serotonin1A, 1C, and2 receptor subtype mRNAs in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900082-1

7 January 2021

Identifiers

10.1016/S0006-8993(98)00082-1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

release_ha2rfubssfdzpmz5vo4tt3m4uu

1 reference

https://api.fatcat.wiki/v0/release/ha2rfubssfdzpmz5vo4tt3m4uu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9593827

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48447583&oldid=1835991431"